Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion.
Gong W, Donnelly CR, Heath BR, Bellile E, Donnelly LA, Taner HF, Broses L, Brenner JC, Chinn SB, Ji RR, Wen H, Nör JE, Wang J, Wolf GT, Xie Y, Lei YL.
Gong W, et al. Among authors: ji rr.
Oncoimmunology. 2021 Nov 13;10(1):1997385. doi: 10.1080/2162402X.2021.1997385. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34858725
Free PMC article.